Abstract
The introduction of chlorpromazine and reserpine for psychiatric use has been followed by a steady increase in the number of psychotropic agents. In the development of new compounds, there have been many attempts to improve the therapeutic indices and to vary the profile of pharmacodynamic activity in accordance with clinical requirements. The number of preparations on the market eases the work of doctors in hospital and general practice and enables them to adapt their treatment plans to individual patients. Inevitably, however, the many drugs available also increase the number and variety of possible toxic reactions and side-effects. This is at once apparent from the different spectra of activity of the individual compounds which often provoke, in man and animals, effects beyond those of their actual psychopharmacological activity. This subject will be considered in greater detail in the chapter on the side-effects of antipsychotic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdullah, S., Miller, O.J.: Effect of drugs on nucleic acid synthesis and cell division in vitro. Dis. Nerv. Syst. 29, 829–833 (1968)
Adams, A.E., Fudge, M.W.: Effects of Reserpine on the reproductive system of immature male mice. J. Exp. Zool. 142, 337–351 (1959)
Adams, H.R.: Clinicopathologic effects of chronic reserpine administration in mongrel dogs. J. Pharm. Sci. 60, 1134–1138 (1971)
Adams, H.R., Manian, A.A., Steenberg, M.L., Buckley, J.P.: Effects of promazine and chlorpromazine metabolites on the cornea. In: The phenothiazines and structurally related drugs. Forrest, S., Carr, C.J., Usdin, E. (eds.), pp. 281–283. New York: Raven 1974
Ahlenius, S., Brown, R., Engel, J., Lundborg, P.: Learning deficits in 4 week old offsprings of the nursing mothers treated with the neuroleptic drug penfluriol. Arch. Exp. Pathol. Pharmakol. 279, 31–37(1973)
Alani, M.D.: Effects of long wave ultraviolet radiation on photosensitizing and related compounds. I. Br. J. Dermatol. 89, 361–365 (1973)
Alani, M.D., Dunne, J.H.: Effects of long wave ultraviolet radiation on photosensitizing and related compounds. II. Br. J. Dermatol. 89, 367–372 (1973)
Alexander, G.J., Machiz, S., Alexander, R.B.: Phenothiazine tranquillizers: Effect of prolonged intake. Adv. Exp. Med. Biol. 27, 151–160 (1972)
Algeri, E.J., Katsas, G.G., McBay, A.J.: Toxicology of some new drugs: Glutethimide, meprobamate and chlorpromazine. J. Forensic Sci. 4, 111–135 (1959)
Almazova, I.G.: Changes in the nervous system in acute poisoning by chlorpromazine in children. Zh. Nevropathol. Psikhiatr. 70, 1499–1501 (1970)
Ananth, J.: Congenital malformations with psychopharmacologic agents. Compr. Psychiatry 16, 437–445 (1975)
Ananth, J., Valles, J.V., Whitelaw, J.P.: Usual and unusual agranulocytosis during neuroleptic therapy. Am. J. Psychiatry 130, 100–102 (1973)
Apgar, V.: Drugs in pregnancy. JAMA 190, 340–341 (1964)
Appleton, W.S., Shader, R.I., DiMascio, A.: Dermatological effects. In: Psychotropic drug side effects. Shader, R.I., DiMascio, A., (eds.), pp. 77–85. Baltimore: Williams & Wilkins 1970
Arieff, A.I., Friedman, E.A.: Coma following nonnarcotic overdosage: Management of 208 adult patients. Am. J. Med. Sci. 266, 405–426 (1973)
Artelli, A., Castello, A.: Effetti della thioridazina sulla sfera genitale femminile nel ratto. Boll. Soc. Ital. Biol. Sper. 44, 269–270 (1968)
Ashford, A., Ross, J.W.: Toxicity of depressant and antidepressant drugs in hyperthyroid mice. Br. Med. J. 1968 II, 217–218
Ayd, F.J., Jr.: Prolonged administration of chlorpromazine (thorazine) hydrochloride. JAMA 169, 1296–1301 (1959)
Ayd, F.J., Jr.: Chlorpromazine: Ten years’ experience. JAMA 184, 51–54 (1963)
Ayd, F.J., Jr.: Children born of mothers treated with chlorpromazine during pregnancy. Clin. Med. 71, 1758–1763 (1964a)
Ayd, F.J., Jr.: Perphenazine: A reappraisal after eight years. Dis. Nerv. Syst. 25, 311–316 (1964 b)
Ayd, F.J., Jr.: Side effects of depot fluphenazines. Adv. Biochem. Psychopharmacol. 9, 301–309 (1974)
Bambas, W.: Zur ambulanten Behandlung der Spätgestose mit Briserin. Ther. Gg. 110, 525–536 (1971)
Barnes, C.D., Eltherington, L.G.: Drug dosage in laboratory animals. Berkeley, Los Angeles, London: University of California 1973
Barry, D., Meyskens, F.L., Becker, Ch.E.: Phenothiazine poisoning. Calif. Med. 118, 1–5 (1973)
Bartolomé, J., Seidler, F.J., Anderson, Th.R., Slotkin, Th.A.: Effects of prenatal reserpine administration on development of the rat adrenal medulla and central nervous system. J. Pharmacol. Exp. Ther. 197, 293–302 (1976)
Baruk, H., Launay, J., Linares, J.O., Segal, O.: Experimentation psycho — pharmacologique animale et essais clinique therapeutique de la thioridazine. Ann. Med. Psychol. (Paris) 1, 129 (1966)
Bayer, R.: Sedierung und Geburtenbeschleunigung mit Triflupromazin. Med. Klin. 61, 725–728 (1966)
Beall, J.R.: A teratogenic study of chlorpromazin, orphenadrine, perphenazine, and LSD-25 in rats. Toxicol. Appl. Pharmacol. 21, 230–236 (1972)
Beall, J.R.: A teratogenic study of four psychoactive drugs in rats. Teratology 8, 214–215 (1973)
Becker, B.A., Hindman, K.L., Gibson, J.E.: Enhanced mortality of selected central nervous system depressants in hypoexcretory mice. J. Pharm. Sci. 57, 1010–1012 (1968)
Bein, H.J.: The pharmacology of rauwolfia. Pharmacol. Rev. 8, 435–483 (1956)
Beliles, R.P.: The influence of pregnancy on the acute toxicity of various compounds in mice. Toxicol. Appl. Pharmacol. 23, 537–550 (1972)
Bercovitz, Z., Page, R.C., De Beer, E.J.: Phenothiazine: Experimental and clinical study of toxicity and anthelmintic value. JAMA 122, 1006–1007 (1943)
Bernstein, H.N.: Ocular drug toxicities. Toxicol. Appl. Pharmacol. 8, 334–335 (1966)
Bertelli, A., Polani, P.E., Spector, R., Seller, M.J., Tuchmann-Duplessis, H., Mercier-Parot, L.: Retentissement d’un neuroleptique, l’halopéridol, sur la gestation et le développement prénatal des rongeurs. Arzneim. Forsch. 18, 1420–1424 (1968)
Berthaux, P., Neuman, M.: Etude pharmacologique et clinique d’un nouvel hypotenseur réserpinique: le N-diéthylanimoéthyl réserpine (DL 152 ou biétaserpine). Arzneim. Forsch. 14, 1040–1045 (1964)
Berti, T., Cima, L.: Einfluß der Temperatur auf die pharmakologische Wirkung des Chlorpromazins. Arzneim. Forsch. 5, 73–74 (1955)
Bethesda: Symposium on side-effects and drug toxicity, including behavioral toxicity. Psychopharmacol. Bull. 4, 56–61 (1967)
Bindon, B.M.: The role of the pituitary gland in implantation in the mouse: Delay of implantation by hypophysectomy and neurodepressive drugs. J. Endocrinol. 43, 225–235 (1969)
Bishun, N., Smith, N., Williams, D.: Chromosomes, mitosis and reserpine. Lancet 1975 I, 926
Björklund, A., Falck, B., Nobin, A.: Failure of neonatally administered reserpine to affect the hypothalamic catecholamines in the adult rat. Endocrinology 85, 788–790 (1969)
Blacker, K.H., Weinstein, B.J., Ellmann, G.L.: Mother’s milk and chlorpromazine. Am. J. Psychiatry 119, 178–179 (1962)
Blackman, J.G., Campion, D.S., Fastier, F.N.: Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse. Br. J. Pharmacol. 14, 112–116 (1959)
Blom van Assendelft, P.M., Dorhout Mees, E.J., Hart, P.G., Reduction of neonatal mortality by treatment of pregnant women suffering from essential hypertension. Ned. Tijdschr. Geneeskd. 112, 1115–1118(1968)
Bobon, D.P.: The Neuroleptics. Basel, München, Paris, New York: Karger 1970
Boet, D.J.: Toxic effects of phenothiazines on the eye. Med. Dissertation, Gravenhage 1970
Boissier, J.-P., Pagny, J.: Etude pharmacodynamique d’un nouveau neroleptique majeur: Le halopéridol (R 1625). Thérapie 15, 479–487 (1960)
Bolton, B.H.: Prolonged chlorpromazine jaundice. Am. J. Gastroenterol. 48, 497–503 (1968)
Boris, A., Milmore, J., Trimai, T.: Some effects of haloperidol on reproductive organs in the female rat. Endocrinology 86, 429–431 (1970)
Boulos, B.M., Davis, L.E., Larks, S.D., Larks, G.G., Sirtori, C.R., Almond, C.H.: Placental transfer of drugs: IV. Placental transfer of chlorpromazine, pentobarbital and phenylbutazone with fetal ECG changes as determined by direct lead tracing. Arch. Int. Pharmacodyn. Ther. 194, 403–414 (1971)
Boyd, E.M.: Chlorpromazine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 128, 75–78 (1960)
Bree, M.M., Cohen, B.J., Abrams, G.D.: Injektion lesions following intramuscular administration of chlorpromazine in rabbits. J. Am. Vet. Med. Assoc. 158, 1910 (1971)
Brock, N., Kreybig, T. von: Experimenteller Beitrag zur Prüfung teratogener Wirkungen von Arzneimitteln an der Laboratoriumsratte. Arch. Exp. Pathol. Pharmakol. 249, 117–145 (1964)
Brookes, L.G., Forrest, I.S.: Chlorpromazine metabolism in sheep. I. In vivo metabolism. Agressologie 12, 245–250 (1971)
Brugmans, J., Verbruggen, F., Dom, J., Schuermans, V.: Prolactin, phenothiazines, admission of mental hospital, and carcinoma of the breast. Lancet 1973 II, 502–503
Buckley, J.P., Steenberg, M.L., Barry III, H., Manian, A.A.: Pharmacological and behavioral effects of mono — and disubstituted chlorpromazine derivatives. In: The phenothiazines and structurally related drugs. Forrest, I.S., Carr, C.J., Usdin, E., (eds.), pp. 617–631. New York: Raven 1974
Buckman, M.T., Peake, G.T.: Prolactin in clinical practice. JAMA 236, 871–874 (1976)
Budnick, I.S., Leikin, S., Hoeck, L.E.: Effect in the newborn infant of reserpine administered ante partum. Am. J. Dis. Child. 90, 286–289 (1955)
Buttle, H.L., Robertson, H.A.: The pharmacological blockade of the initiation but not of the maintenance of sexual receptivity of the ewe. J. Endocrinol. 39, 115–116 (1967)
Callear, J.F.F., van Gestel, J.F.E.: An analysis of the results of field experiments in pigs in the U.K. and Ireland with the sedative neuroleptic azaperone. Vet. Rec. 89, 453–458 (1971)
Carminati, G.M.: Attivita comparata di svariati farmaci in alcuni tests sperimentali di studio del compartomento. Arch. Intern. Pharmacodyn. Ther. 181, 68–93 (1969)
Cascio, G., Manghisi, E., Erba, R., Magistretti, M.J.: 4-Aminobutirofenoni ad attivita ipotensiva. Farmaco. [Sci.] 31, 442–456 (1976)
Cazzullo, C.L., Giordano, P.L., Andreola, M.L.: Etudes cytopathologiques des effets des drogues psychotropes sur la cellule nerveuse. Agressologie 9, 575–589 (1968)
Cerletti, A., Meier-Ruge, W.: Toxicological studies on phenothiazine induced retinopathy. Proc. Eur. Soc. Study Drug Toxi. 9, 170–188 (1968)
Cerny, V.A.: Influence of the hypothalamus on the mating behavior of the female cat. Diss. Abstr. Int. B 31, 3670–3671 (1970)
Chand, N., Gupta, T.K., Bhargava, K.P.: A study of anti-ovulatory activity of haloperidol in rabbits. Jpn. J. Pharmacol. 23, 827–829 (1973)
Chatterjee, A., Harper, M.J.K.: Interruption of implantation and gestation in rats by reserpine, chlorpromazine and ACTH: Possible mode of action. Endocrinology 87, 966–969 (1970)
Chioreanu, L., Wiener, F.: Die mutagene Wirkung von Haloperidol und Thioproperazil auf Mäusechromosomen. Med. Exp. 17, 417–426 (1968)
Christensen, E., Möller, J.E., Faurbys, A.: Neuropathological investigation of 28 brains from patients with dyskinesis. Acta Psychiatr. Scand. 46, 14–23 (1970)
Christensen, J.A., Hernestam, S., Lassen, J.B., Sterner, N.: Pharmacological and toxicological studies on -(4-methyl piperidino)-p-fluorobutyrophenone (FG 5111) — a new neuroleptic agent. Acta Pharmacol. Toxicol. (Copenh.) 23, 109–132 (1965)
Cohlan, S.Q.: Fetal and neonatal hazards from drugs administered during pregnancy. N.Y. State J. Med. 64, 493–499 (1964)
Collier, H.B., Mack, G.E., Jr.: Vitamin B and phenothiazine anaemia in dogs. Can. J. Res. 22, 1–11 (1944)
Cordelli, A.: Indagini sull’azione della clorpromazina sui processi di glicuroniugazione della bilirubina in fegato di ratto isolato e perfuso. Boll. Soc. Ital. Biol. Sper. 44, 1217–1219 (1968)
Courvoisier, S., Fournel, J., Ducrot, R., Kolsky, M., Koetschet, P.: Propriétés pharmacodynamiques du chlorhydrate de chloro-3 (diméthylamino-3’propyl)-10 phénothiazine (4.560 R.P.). Arch. Int. Pharmacodyn. Ther. 92, 305–361 (1953)
Coutselinis, A., Boukis, D., Kentarchou, P.: Haloperidol concentrations in blood in cases of acute intoxication. Clin. Chem. 23, 900 (1977)
Cuisset, P., Roujas, F.: Rappel de pharmacologique pratique des phénothiazines et des butyrophénones. Ann. Anesthésiol. 17, 1025–1032 (1976)
Damrau, F.: Peptic ulcers induced in white rats by reserpine and stress. Am. J. Gastroenterol. 35, 612–618 (1961)
Danner, S.: Cardiovasculaire complicaties bij gebruik van fenothiazine en imipramine-derivaten. Ned. Tijdschr. Geneeskd. 115, 1707–1708 (1971)
Davis, J.M., Bartlett, E., Termini, B.A.: Overdosage of psychotropic drugs: A review. Part I: Major and minor tranquilizers. Dis. Nerv. Syst. 29, 157–164 (1968)
De C.Baker, S.B., Tucker, M.J.: Changes in the reproductive organs of rats and dogs treated with butyrophenones and related compounds. Proc. Eur. Soc. Study Drug Toxi. 9, 113–118 (1968)
De Feo, V.J.: Modification of the menstrual cycle in rhesus monkeys by reserpine. Science 124, 726–727 (1956)
Degkwitz, R., Heushgem, C., Hollister, L.E., Jacob, J., Julou, L., Lambert, P.A., Marsboom, R., Meier-Ruge, W., Schaper, W.K.A., Tuchmann-Duplessis, H.C.: Toxicity and side effects in man and in the laboratory animal. In: The neuroleptics. Bobon, D.P., Janssen, P.A.J., Bobon, J. (eds.), pp. 71–84. Basel, München, Paris, New York: Karger 1970
Deglin, S.M., Deglin, J.M., Chung, E.K.: Drug-induced cardiovascular diseases. Drugs 14, 29–40(1977)
Delay, J., Deniker, P.: C.R. du congrès des aliénists et neurologistes de langue Française, Luxembourg, p. 514. Paris: Masson 1952
Delay, J., Deniker, P.: Les nouveaux médicaments psychotropes. Paris: Masson 1961
Deneau, G., Yanagita, T., Seevers, M.H.: Self-administration of psychoactive substances by the monkey. Psychopharmacolia 16, 30–48 (1969)
Desmond, M.M., Yanagita, T., Seevers, M.H.: Management of toxemia of pregnancy with re-serpine. Obstet. Gynecol. 10, 140–145 (1957)
Dewsbury, D.A.: Copulatory behavior of male rats following reserpine administration. Psy-chonomic Sci. 22, 177–179 (1971)
Dewsbury, D.A., Davis, H.N. (1970) Effects of reserpine on the copulatory behavior of male rats. Physiol. Behav. 5, 1331–1333 (1970)
Djahanguiri, B., Sadeghi, D., Hemmati, S.: The production of acute gastric ulcer by promethazine hydrochloride in the guinea pig. Toxicol. Appl. Pharmacol. 12, 568–569 (1968)
Döring, G.K., Stephan, G.: Über die Beeinflussung der Genitalfunktion weißer Ratten durch das Rauwolfiaalkaloid Reserpin. Arch. Gynaekol. 191, 570–575 (1959)
Domino, E.F.: Human pharmacology of tranquilizing drugs. Clin. Pharmacol. Ther. 3, 599–664 (1962)
Donnewald, H.N.: L’intoxication aiguë par les phénothiazines chez l’adulte, à propos de 112 cas. Eur. J. Toxicol. Environ. Hyg. 3, 167–178 (1970)
Doteuchi, M.: Studies on the experimental gastrointestinal ulcers produced by reserpine and stress. II. Ulcerogenic activities of reserpine and its analogues. Jpn. J. Pharmacol. 18, 130–138 (1968)
Dreyfus, B., Bernard, J., Josso, F., Samama, M., Pequignot, H.: Les hémolyses médicamenteuses. Presse Med. 76, 1009–1012 (1968)
Druga, A.: Studies on the teratogenic effect of Perphenazin in rats. Gyogyszereszet 18, 462 (1974)
Dujovne, C.A., Zimmerman, H.J.: Cytotoxicity of phenothiazines on changed liver cells as measured by enzyme leakage. Proc. Soc. Exp. Biol. Med. 131, 583–587 (1969)
Dujovne, CA., Levy, R., Zimmerman, H.J.: Hepatotoxicity of phenothiazines in vitro as measured by loss of aminotransferases to surrounding media. Proc. Soc. Exp. Biol. Med. 128, 561–563 (1968)
Ebert, M.H., Shader, R.I.: Hematological effects. In: Psychotropic drug side effects. Shader, R.I., DiMascio, A. (eds.), pp. 164–174. Baltimore: Williams & Wilkins 1970
Einer-Jensen, N., Secher, N.J.: Diminished weight of rat foetuses after treatment of pregnant rats with haloperidol. J. Reprod. Fertil. 22, 591–594 (1970)
Elert, R.: Die medikamentöse perinatale Schädigung. Therapiewoche 19, 218–221 (1969)
Elis, J.: The relationship between the stage of prenatal development and toxic effects of drugs. Proc. Eur. Soc. Toxicol. 16, 133–137 (1975)
Ernas, S., Fyrö, B.: Gastric and duodenal ulcers in cats following reserpine. Acta Physiol. Scand. 71, 316–322(1967)
Engel, J., Ahlenius, S., Brown, R., Lundborg, P.: Behavioral effects in offspring of nursing mothers given neuroleptic drugs. Proc. Eur. Soc. Study Drug Toxi. 15, 20–24 (1974)
Epstein, S.S., Shafner, H.: Chemical mutagens in the human environment. Nature 219, 385–387 (1968)
Eränkö, O.V., Hopsu, E., Kivalo, E., Telkkä, A.: Effect of prolonged administration of reserpine on the endocrine glands of the rat. Nature 180, 1130 (1957)
Ershova, V.P.: The effect of chronic injections of chlorpromazine on the oogenesis and development of the progeny in animals (Albino mice). Farmakol. Toksikol. 38, 473–476 (1975)
Fairweather, D.V.I.: Nausea and vomiting in pregnancy. Am. J. Obstet. Gynecol. 102, 135–175 (1968)
Forrest, I.S., Kosek, J.C., Aber, R.C., Serra, M.T.: Rabbit as a model for chlorpromazine-induced hyperpigmentation of the skin. Biochem. Pharmacol. 19, 849–852 (1970)
Fossati, C.: Effetti collaterali e tossici degli psicofarmaci. Clin. Ter. 76, 265–281 (1976)
Frankova, S.: Drug-induced changes in the maternal behavior of rats. Psychopharmacology (Berlin) 53, 83–87 (1977)
Frejaville, J.P., Guyochin, A., Gaultier, M.: Intoxications aiguës par les amines phénothiazini-ques à propos de 152 cas. Eur. J. Toxicol. Environ. Hyg. 3, 179–187 (1970)
Friebel, H. Flick, H., Reichle, C.: Beziehungen zwischen der chemischen Konstitution und der pharmakologischen Wirkung einiger Phenothiazinderivate. Arzneim. Forsch. 4, 171–174 (1954)
Fuller, R.: Sexual changes in the male rat following chronic administration of reserpine. Nature 200, 585–586 (1963)
Gajdos, P., Berger, F.D., Rapin, M., Goulon, M.: Etude hemodynamique de 14 comas toxique (Barbiturique-phénothiazines-tranquillisants). Eur. J. Toxicol. Environ. Hyg. 3, 24–35 (1970)
Gaultier, M., Deroviche-Fahti: Les intoxications par les butyrophénones. Eur. J. Toxicol. Environ. Hyg. 4, 385–402 (1971)
Gaunt, R., Renzi, A.A., Antonchak, N., Miller, G.J., Gilman, M.: Endocrine aspects of the pharmacology of reserpine. Ann. N.Y. Acad. Sci. 59, 22–35 (1954)
Gauron, E.F., Rowley, V.N.: Effects on offspring behavior of mother’s early chronic drug experience. Psychopharmacologia 16, 5–15 (1969)
Gauron, E.F., Rowley, V.N.: Cross-generational effects resulting from an early maternal chronic drug experience. Eur. J. Pharmacol. 15, 171–175 (1971)
Gauron, E.F., Rowley, V.N.: Effects on offspring behavior of early drug experience and cross-fostering in parent rats. J. Pediatr. 83, 155 (1973)
Gebhart, E.: Zur Frage der erbgutschädigenden Nebenwirkungen von psychotropen Substanzen. Fortschr. Med. 97, 45–48, 105–106 (1979)
Gerhardt, J., Kurcz, M.: Effect of neonatal treatment with reserpine on FSH, LH and LTH production of the pituitary in rat. Acta Physiol. Acad. Sci. Hung. [Suppl. 2], 33, 82–83 (1967)
Gerhard, J.-P., Franck, H., Sommer, S., Mack, G.: L’incidence ophthalmologique du traitement aux phénothiazines. Oto Noro Oftalmol. 47, 71–77 (1975)
Ghate, V.R.: Antipsychotic agents. N. C. Med. J. 34, 859–865 (1973)
Giertz, H., Hahn, F., Lange, A.: Zur Toxikologie des Phenothiazins. Klin. Wochenschr. 32, 983–984 (1954)
Givant, Y., Shani, J., Goldhaber, G., Serebrenik, R., Sulman, F.G.: Pharmacology of three mammotropic butyrophenones in the rat. Arch. Int. Pharmacodyn. Ther. 205, 317–327 (1973)
Goldman, A.S., Yakovac, W.C.: Teratogenic action in rats of reserpine alone and in combination with salicylate and immobilization. Proc. Soc. Exp. Biol. Med. 118, 857–862 (1965)
Golub, M., Kornetsky, C.: Modification of the behavioral response to drugs in rats exposed prenatally to chlorpromazine. Psychopharmacologia 43, 289–291 (1975)
Gordon, S., Balazs, T.: Cataractogenicity of various drugs in rats. Toxicol. Appl. Pharmacol. 10, 393 (1967)
Gouret, C, Bouvet, P., Raynaud, G.: Activité psychotrope de la fénapérone et comparaison avec quelques neuroleptiques chez la souris et le rat. C.R. Soc. Biol. (Paris) 167, 1366–1370 (1973)
Greiner, A.C., Nicolson, G.A.: Pigment deposition in viscera associated with prolonged chlorpromazine therapy. Can. Med. Assoc. J. 91, 627–635 (1964)
Gunne, L.-M., Barany, S.: Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology (Berlin) 50, 237–240 (1976)
Gupta, M.B., Tangri, K.T., Bhargava, K.P.: Mechanism of ulcerogenic activity of reserpine in albino rats. Eur. J. Pharmacol. 27, 269–271 (1974)
Guyonnet, J.C., Julou, L., Ducrot, R., Detaille, J.Y., Laffargue, B., Leau, O.: Etude des propriétés pharmacologiques générales de la méthylsulfonyl-2 (carbamoyl-4 piperidino)-3 propyl-10 phénothiazine ou métopimazine (9965 R.P.). C. R. Acad. Sei [D] (Paris) 266, 2365–2368 (1968)
Häggendahl, J., Lindqvist, M.: Behavior and monoamine levels during longterm administration of reserpine to rabbits. Acta Physiol. Scand. 57, 431–436 (1963)
Hänel, L.: Beitrag zur Toxikologie der gebräuchlichsten Anthelmintica. Pharmazie 5, 18–23 (1950)
Halpern, B.-N., Ducrot, R.: Recherches expérimentales sur une nouvelle série chimique de corps loués de propriétés antihistaminiques puissantes: Les dérivés de la thiodiphénylami-ne. C.R. Soc. Biol. (Paris) 140, 361–363 (1946)
Halpern, B.-N., Perrin, G., Dews, P.-B.: Pouvoir anesthésique local de quelques antihistaminiques de synthèse. Relation entre l’action anesthésique et l’action antihistaminique. J. Physiol. (Paris) 40, 210–214 (1948)
Hanson, J.W., Oakley, G.P.: Haloperidol and limb deformity. J.A.M.A. 231, 26 (1975)
Harper, M.J.K.: Pharmacological control of reproduction in women. Prog. Drug Res. 12, 47–136 (1968)
Harrington, F.E., Eggert, R.G., Wilbur, R.D., Linkenheimer, W.H.: Effect of coitus on chlorpromazine inhibition of ovulation in the rat. Endocrinology 79, 1130–1134 (1966)
Hays, G.B.: Tranquilizers may cause skin discoloration in some patients. J.A.M.A. 191, 33 (1965)
Henkes, H.E., Canta, L.R.: Drug-induced disorders of the eye. Proc. Eur. Soc. Study Drug Toxi. 14, 146–153 (1973)
Heywood, R., Palmer, A.K.: Prolonged toxicological studies in the rat and beagle dog with methylperone hydrochloride, with embryo toxicity studies in the rabbit and rat. Farmaco [Prat.] 29, 586–593 (1974)
Hochuli, E., Weiche, V.: Zur Dauermedikation mit hypotensiven Substanzen in graviditate. Geburtshilfe Frauenheilkd. 1, 32–39 (1972)
Hoffeld, D.R., Webster, R.L.: Effect of injection of tranquillizing drugs during pregnancy on offspring. Nature 205, 1070–1072 (1965)
Hoffeld, D.R., Webster, R.L., McNew, J.: Adverse effects on offspring of tranquillizing drugs during pregnancy. Nature 215, 182–183 (1967)
Hoffeld, D.R., McNew, J., Webster, R.L.: Effects of tranquillizing drugs during pregnancy on activity of offspring. Nature 218, 357–358 (1968)
Hollister, L.E.: Adverse reactions to phenothiazines. J.A.M.A. 189, 311–313 (1964)
Hollister, L.E.: Overdoses of psychotherapeutic drugs. Clin. Pharmacol. Ther. 7, 142–146 (1966)
Honma, T., Sasajima, K., Ono, K., Kitagawa, S., Inaba, Sh., Yamamoto, H.: Synthesis and preliminary pharmacology of a novel butyrophenone derivate I D-4708. Arzneim. Forsch. 24, 1248–1255 (1974)
Horvath, C., Druga, A., Mold, C.: The effect of phenothiazine derivatives on rat embryos. Teratology 4, 489 (1971)
Ison, A., Blank, H.: Testing drug phototoxity in mice. J. Invest. Dermatol. 49, 508–511 (1967)
Itoh, T., Koseki, Y., Ando, T., Saka, M., Nakaya, Sh.: Acute and subacute toxicities of levomethiomeprazine. Jpn. J. Pharmacol. 24, 39 (1974)
Itoh, T., Ando, F., Seki, M., Nakaya, Sh.: Effect of chlorpromazine on the reproduction in rats. Jpn. J. Pharmacol. [Suppl.] 26, 90P (1976)
Iven, H.: Nebenwirkungen von Arzneimitteln. 2. Antihypertensiva. Prakt. Arzt. 16, 109–115 (1979)
Jandhyala, B.S., Clarke, D.E., Buckley, J.P.: Effects of prolonged administration of certain antihypertensive agents. J. Pharm. Sc. 63, 1497–1513 (1974)
Janssen, P.A.J.: Toxicology and metabolism of butyrophenones. Proc. Eur. Soc. Study Drug Toxi. 9, 107–112(1968)
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L., Dresse, A., Lenaerts, F.M., Pinchard, A., Schaper, W.K.A., Van Nueten, J.M., Verbruggen, F.J.: Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. Arzneim. Forsch. 18, 261–279 (1968)
Jelinek, V., Zikmund, E., Reichlova, R.: L’influence de quelques médicaments psychotropes sur le développement du foetus chez le rat. Thérapie 22, 1429 (1967)
Johnson, B.E.: Cellular mechanism of chlorpromazine photosensitivity. Proc. R. Soc. Med. 67, 871–873 (1974)
Johnson, F.P., Boyd, D.A., Sayre, G.P., Tyce, F.A.J.: Sudden death of catatonic patient receiving phenothiazine. Am. J. Psychiatry 121, 504–507 (1964)
Julou, L., Ducrot, R., Ganter, P., Maral, R., Populaire, P., Durel, J., Huttric, E., Myon, J., Pascal, S., Pasquet, J.: Toxicité à terme, effets secondaires et métabolisme des neuroleptiques phénothiaziniques. Proc. Eur. Soc. Study Drug Toxi. 9, 11–51 (1968)
Julou, L., Bourat, G., Ducrot, R., Fournel, J., Garret, C.: Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters. Acta Psy-chiatr. Scand. [Suppl.] 241, 9–30 (1973)
Kalter, H.: Teratogenicity, embryolethality and mutagenicity of drugs of dependence. In: Chemical and biological aspects of drug dependence. Mulé, S.J., Brill, H. (eds.), pp. 413–448. Cleveland, Ohio: CRC Presss 1974
Kamyanov, I.M.: The clinical picture of chlorpromazine poisoning. Zh. Nevropatol. Psikhiatr. 65, 918–919 (1965)
Kanoh, S., Moriyama, I.S.: Effects of reserpine on the pregnant rat: 2nd report. Teratology 16, 110 (1977)
Kapur, B.M., Sellers, E.M., Marshman, J.A., MacLeod, S., Kaplan, H., Giles, H.: Predictability of emergency drug analysis. Clin. Chem. 23, 1160 (1977)
Karkischenko, N.N.: Some morpho-physiological changes of the brain in the presence of chlorpromazine during chronic experiments. Farmakol. Toksikol. 31, 156–159 (1968)
Kehl, R., Czyba, J.C.: Sur l’action galactogène de la réserpine chez la lapine. J. Physiol. (Paris) 54, 356–357 (1962)
Kehl, R., Audibert, A., Gage, C., Amarger, J.: Action de la réserpine à différentes périodes de la gestation chez la lapine. C. R. Soc. Biol. (Paris) 150, 2196–2199 (1956)
Kleinsorge, H., Rösner, K.: Toxikologie und Nebenwirkungen der Phenothiazinderivate. In: Die Phenothiazinderivate in der Medizin. Kleinsorge, H., Rösner, K. (eds.), pp. 173–190. Jena: Fischer 1958
Kluge, H., Hartmann, W., Wieczorek, V.: Begleitwirkungen von Neuroleptika aus biochemischer Sicht. Z. Ärztl. Fortbild. (Jena) 68, 1207–1209 (1974)
Knowles, J.A.: Excretion of drugs in milk. A review. J. Pediatr. 66, 1068–1082 (1965)
Kopelman, A.E., McCullar, F.W., Heggeness, L.: Limb malformations following maternal use of haloperidol. J.A.M.A. 231, 62–64 (1975)
Kovacic, B., Robinson, R.L.: The effect of reserpine on catecholamine levels in the gravid rat and its offspring. J. Pharmacol. Exp. Ther. 152, 37–41 (1966)
Kozuka, S.: Inhibiting effect of reserpine and female sensitivity in hepatic tumor induction with 2.7-diacetamidofluorene in SMA/Ms strain. Cancer Res. 30, 1384–1386 (1970)
Kris, E.B.: Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr. Ther. Res. 7, 785–789 (1965)
Kurtz, D., Feuerstein, J., Weber, M., Girardel-Reeb, M., Rohmer, F.: Intérêt de la surveillance électroencéphalographique dans le cadre de la réanimation des comas par intoxication médicamenteuse aiguë. Rev. Electroencephalogr. Neurophysiol. Clin. 1, 171–189 (1971)
La Barre, J., Desmarez, J.-J.: A propos des phénomènes hypersécrétoires et des manifestations ulcéreuses gastriques apparaissant chez le rat traité par la réserpine. C. R. Soc. Biol. (Paris) 151, 1451–1452(1957)
Laborit, H., Huguenard, P.: L’hibernation artificielle par moyens pharmacodynamiques et physiques en chirurgie. Presse Med. 59, 1329 (1951)
Laborit, H., Huguenard, P., Alluaume, R.: Un nouveau stabilisateur végétatif (Le 4560 RP). Presse Med. 60, 206–208 (1952)
Lacassagne, A., Hurst, L., Rosenberg, A.J.: Influence de la chlorpromazine et de la réserpine sur la cancérisation expérimentale du foie chez le rat. CR. Acad. Sci. [D] (Paris) 249, 903–905 (1959)
Land, R.B.: Ovulation rate of finn-dorset sheep following unilateral ovariectomy or chlorpromazine treatment at different stages of the oestrous cycle. J. Reprod. Fertil. 33, 99–105 (1973)
Landyshev, Y.S., Pronena, E.I., Markelov, I.P.: A fatal case of acute reserpine poisoning. Klin. Med. 47, 141–142 (1969)
Lapolla, A., Nash, L.R.: Two suicide attempts with chlorpromazine. Am. J. Psychiatry 121, 920–922 (1965)
Lau, C., Bartolomé, J., Seidler, F.J., Slotkin, T.A.: Critical periods for effects of prenatal reserpine administration on development of rat brain and adrenal medulla. Neuropharmacology 16, 799–809 (1977)
Lechat, P., Fontagné, J., Flouvat, B.: Toxicité aiguë de quelques neuroleptiques chez des animaux préalablement traités par un I.M.A.O. Proc. Eur. Soc. Study Drug Toxi. 9, 156–158 (1968)
Lehman, H.E., Ban, T.A.: Sex differences in long-term adverse effects of phenothiazine. Adv. Biochem. Psychopharmacol. 2, 249–254 (1974)
Lehtinen, P., Hyyppä, M., Lampinen, P.: Sexual behavior of adult rats after a single neonatal injection of reserpine. Psychopharmacologia 23, 171–179 (1972)
Lewis, P.D., Pathel, A.J., Bendek, G., Balázs, R.: Do drugs acting on the nervous system affect cell proliferation in the developing brain. Lancet 7977 I, 399–401 (1977)
Lindqvist, N.G., Sjostrand, S.E., Ullberg, S.: Accumulation of chorio-retinotoxic drugs in the foetal eye. Acta Pharmacol. Toxicol. (Copenh.) [Suppl. 7] 28, 64 (1970)
Lipton, M.H., DiMascio, A., Killam, K.F.: Psychopharmacology. New York: Raven 1978
Ljunggren, B.: Phenothiazine phototoxicity: Toxic chlorpromazine photoproducts. J. Invest. Dermatol. 68, 313–317 (1977)
Ljunggren, B., Möller, H.: Phenothiazine phototoxicity: An experimental study on chlorpromazine and related tricyclic drugs. Acta Derm. Venereol. (Stockh.) 57, 325–329 (1977 a)
Ljunggren, B., Möller, H.: Phenothiazine toxicity: An experimental study on chlorpromazine and its metabolites. J. Invest. Dermatol. 68, 313–317 (1977b)
Loggie, J.M.H., Saito, H., Kahn, I., Fenner, A., Gaffney, Th.E.: Accidental reserpine poisoning: Clinical and metabolic effects. Clin. Pharmacol. Ther. 8, 692–695 (1967)
Lu, K.-H., Amenomori, Y., Chen, C., Meites, J.: Effects of central acting drugs on serum and pituitary prolactin levels in rats. Endocrinology 87, 667–672 (1970)
Lundborg, P.: Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mothers. Brain Res. 44, 684–687 (1972)
Maickel, R.P., McGlynn, M., Snodgrass, W.R.: Some toxicological aspects of the chronic administration of phenothiazine tranquilizers. Toxicol. Appl. Pharmacol. 17, 312 (1970)
Maickel, R.P., Braunstein, M.C., McGlynn, M., Snodgrass, W.R., Webb, R.W.: Behavioral, biochemical and pharmacological effects of chronic dosage of phenothiazine tranquilizers in rats. In: The phenothiazines and structurally related drugs. Forrest, S., Carr, C.J., Usdin, E. (eds.), pp. 593–616. New York: Raven 1974
Malizia, E., Signore, L., Crimi, G.: Chlorpromazine plus thiorazidine poisoning and treatment with extracorporal dialysis. Acta Pharmacol. Toxicol. (Copenh.) [Suppl. 2] 41, 163–170 (1977)
Manson-Bahr, P.: Phenothiazine as an anthelmintic in threadworm and roundworm infections. Lancet 1940 II, 808
Marcus, S.M., Borzelleca, J.F.: Observations on reserpine-induced bradycardia, Arch. Int. Pharmacodyn. Ther. 174, 12–16 (1968)
Markiewicz, L.: Biochemical and functional effects of longterm administration of reserpine in mice. Acta Physiol. Scand. 58, 376–380 (1963)
Marquardt, H.: Reserpine and chemical carcinogenesis. Lancet 1975I, 925–926 (1975)
Marsboom, R.: On the pharmacology of azaperone, a neuroleptic used for the restraint of wild animals. Acta Zool. Pathol. Antverp. 48, 155–161 (1969)
Martins, M.J.: Sur l’influence de la réserpine dans le cycle oestral du rat. C.R. Soc. Biol. (Paris) 162, 1020–1023(1968)
Massey, L.W.C.: Skin pigmentation, corneal and lens opacities with prolonged chlorpromazine treatment. Can. Med. Assoc. J. 92, 186–187 (1965)
Mayer, G., Meunier, J.-M.: Réserpine et progestation chez la ratte. Survie des oeufs en phase latente et ovoimplantations normales ou retardées, provoquées par l’oestrègène. C. R. Acad. Sci. [D] (Paris) 248, 3355–3357 (1959)
McDonald, C.J., Creasy, W.A., Howard, R.O.: Chlorpromazine toxic ocular manifestations in guinea pigs. Clin. Res. 14, 492 (1966)
McDonald, C.J., Creasy, W.A., Howard, R.O.: Chlorpromazine oculocutaneous pigmentation. Clin. Res. 15, 252 (1967)
Meier-Ruge, W.: Eye toxicity. Proc. Eur. Soc. Study Drug Toxi. 14, 133–145 (1973)
Meldrum, B.S., Anlezark, G.M., Marsden, L.D.: Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain 100, 313–326 (1977)
Mercier, J., Schmitt, J., Aurousseau, J., Etzensperger, P., Bonifay, D.: Etude pharmacologique d’un nouveau neuroplégique. Le maléate acide de l’acétyl-3-diméthylamino-3, propyl-10-phénothiazine: 1.522 Cb.I -toxicité. Action sur le système nerveux central et périphérique. Arch. Int. Pharmacodyn. Ther. 113, 53–75 (1957)
Mikhailova, T.V., Terekhina, A.I., Gilev, A.P.: Pharmacological properties of dixyrazine. A new neuroleptic of the phenothiazine series. Farmakol. Toksikol. 32, 28–31 (1969)
Mikhailova, T.V., Terekhina, A.I., Gilev, A.P.: Chlorpromazine plus thiorazidine poisoning and treatment with extracorporal dialysis. Acta Pharmacol. Toxicol. (Copenh.) [Suppl. 2], 41, 163–170 (1977)
Mills, L.C.: Drug-induced impotence. Amer. Fam. Physician 12, 104–106 (1975)
Mishkinsky, J., Lajtos, Z.K., Sulman, F.G.: Initiation of lactation by hypothalamic implantation of perphenazine. Endocrinology 78, 919–922 (1966)
Mishkinsky, J., Khazen, K., Givant, Y., Dikstein, S., Sulman, F.G.: Mammatropic and neuroleptic effects of butyrophenones in the rat. Arch. Int. Pharmacodyn. Ther. 179, 94–105 (1969)
Mitrofanov, V.S.: Toxicity of triftazine with its repeated introduction. Farmakol. Toxikol. 37, 462–464 (1974)
Moayer, M.: Phenothiazine im Tierexperiment und bei Hyperemesis gravidarum. Med. Klin. 62, 1137–1141 (1967)
Moccetti, T.: Kardiotoxische Medikamente. Bern, Stuttgart, Wien: Huber 1977
Moriarity, A.J.: Trifluoperazine and congenital malformations. Can. Med. Assoc. J. 88, 97 (1963)
Moriyama, I.S., Kanoh, S.: Effects of reserpine on the pregnant rat. Teratology 14, 247 (1976)
Murphree, O.D., Monroe, B.L., Seager, L.D.: Survival of offspring of rats administered phenothiazines during pregnancy. J. Neuropsychiatry 3, 295–297 (1962)
Nair, V.: Prenatal exposure to drugs: Effect of the development of brain monoamin systems. Adv. Behav. Biol. 8, 171–211 (1974)
Neave, R.: Immobilisation and anaesthesia of the pig. Vet. Rec. 92, 272 (1973)
Nelemans, F.A.: Psychopharmaca in traffic. Ned. Tijdschr. Geneeskd. 112, 1862–1867 (1968)
Nicoloff, D.M., Stone, N.H., Leonard, A.S., Doberneck, R., Wangenstein, O.H.: Effect of reserpine on peptic ulceration and gastric blood flow in dogs. Proc. Soc. Exp. Biol. Med. 106, 877–880 (1961)
Niemegeers, C.J.E., Janssen, P.A.J.: Bromoperidol, a new potent neuroleptic of the butyrophenone series. Arzneim. Forsch. 24, 33–45 (1974)
Niemegeers, C.J.E., van Nueten, J.M., Janssen, P.A.J.: Azaperone, a sedative neuroleptic of the butyrophenone series with pronounced anti-agressive and anti-shock activity in animals. Arzneim. Forsch. 24, 1798–1806 (1974)
Nieschulz, O., Popendiker, K., Sack, K.-H.: Pharmakologische Untersuchungen über N-Alkylpiperidyl-phenothiazin-derivate. Arzneim. Forsch. 4, 232–242 (1954)
Nishimura, H., Tanimura, T.: Clinical aspects of the teratogenicity of drugs. Amsterdam, Oxford: Excerpta Medica 1976
Noble, J.F., Sparano, B.M.: Some toxicologic effects of high doses of the nonaddicting analgesic agent methotrimeprazine. Toxicol. Appl. Pharmacol. 8, 349 (1966)
Oberst, F.W., Crook, J.W.: Behavioral, physical and pharmacodynamic effects of haloperidol in dogs and monkeys. Arch. int. Pharmacodyn. Ther. 167, 450–464 (1967)
O’Donoghue, S.E.F.: Distribution of pethidine and chlorpromazine in maternal, foetal and neonatal biological fluids. Nature 229, 124–125 (1971)
O’Donoghue, S.E.F.: Metabolic activity in the human foetus and neonate as shown by administration of chlorpromazin. J. Physiol. (London) 242, 105–106 (1974)
Ordy, J.M., Samorajski, T., Collins, R.L., Rolsten, C.: Prenatal chlorpromazine effects on liver, survival and behavior of mice offspring. J. Pharmacol. Exp. Ther. 151, 110–125 (1966)
Peele, R., Loetzen, I.S.von: Phenothiazine deaths: A cortical review. Am. J. Psychiatry. 130, 306–308 (1973)
Perry, T.L., Culling, C.F.A., Berry, K., Hansen, S.: 7-Hydroxychlorpromazine: Potential toxic drug metabolite in psychiatric patients. Science 146, 81–83 (1964)
Peters, U.H.: Akute Intoxikationen mit Psychopharmaka. Therapiewoche 14, 393–394 (1964)
Pfeifer, HJ., Greenblatt, D.J., Koch-Weser, J.: Clinical toxicity of reserpine in hospitalized patients: A report from the Boston collaborative drug surveillance program. Am. J. Med. Sci. 271, 269–276 (1976)
Pisciotta, A.V., Hinz, J.H.: Inhibition of DNA synthesis by chlorpromazine. J. Lab. Clin. Med. 66, 1011 (1965)
Platts, M.M., Usher, A., Stentiford, N.H.: Phenelzine and trifluoperazine poisoning. Lancet 1965 II, 738
Plummer, A.J., Earl, A., Schneider, J.A., Trapold, J., Barrett, W.: Pharmakology of rauwolfia alkaloids, including reserpine. Ann. N.Y. Acad. Sci. 59, 8–21 (1954)
Poeck, K.: Schwierige diagnostische Probleme bei Arzneimittelvergiftungen. Med. Welt 47, 2576–2585 (1968)
Pomme, B., Girard, J., Debost, M.: Troubles de la sexualité et médications psychotropes. Ann. Med. Psychol. (Paris) 1, 551–562 (1965)
Popov, T.: Untersuchungen über die Widerstandsfähigkeit der Lysosomen-Membranen: III. Schutz der Leber-Lysosome vor der schädigenden Wirkung der Chlorpromazins durch Riboflavin in vivo. Z. Naturforsch. [B] 22, 1157–1159 (1967)
Psychosos, A.: The effects of reserpine and chlorpromazine on sexual function. J. Reprod. Fertil. [Suppl.] 4, 47–59 (1968)
Ravina, J.-H.: Les thérapeutiques dangereuses chez la femme enceinte. Presse Méd. 72, 3057–3059 (1964)
Rieder, R.O., Rosenthal, D., Wender, P., Blumenthal, H.: The offspring of schizophrenics. Fetal and neonatal deaths. Arch. Gen. Psychiatry 32, 200–211 (1975)
Rise, A.: Drug and embryo Tidsskr. Nor. Laegeforen. 96, 446–447 (1976)
Ritama, V., Vapaatalo, H.I., Neuvonen, P.J., Idaenpaeaen. Heikkilae, J.E., Paasonen, M.K.: Phenothiazines and intestinal dilatation. Lancet 1969 I, 470
Roe, F.J.C.: The relevance of preclinical assessment of carcinogenesis. Clin. Pharmacol. Ther. 7, 77–111 (1966)
Roizin, L., True, Ch., Knight, M.: Structural effects of tranquilizers. Proc. Assoc. Res. Nerv. Ment. Dis. 37, 285–324 (1957)
Roman, I.C.: Rat and human chromosome studies after promazine medication. Br. Med. J. 1969 IV, 112
Rosecrans, J.A.. Effects of route of administration on the chronic toxicity of reserpine. Psychopharmacologia 10, 452–456 (1967)
Roubein, I.F., Samuelly, M., Keup, W.: The toxicity of chlorpromazine and mescaline on mouse cerebellum and fibroblast cells in culture. Acta Pharmacol. Toxicol. (Copenh.) 33, 326–329 (1973)
Roux, C.: Action tératogène de la prochlorpémazine. Arch. Fr. Pédiatr. 16, 968–971 (1959)
Rumeau-Rouquette, C.: Goujard, Huel, G.: Les médicaments du systeme nerveux sont-ils tératogènes? Arch. Fr. Pédiatr. 33, 5–10 (1976)
Rumeau-Rouquette, C., Goujard, J., Huel, G.: Possible teratogenic effect of phenothiazine in human beings. Teratology 15, 57–64 (1977)
Sackler, A.M., Weltman, A.S., Bradshaw, M., Hielman, F.: The effects of reserpine on histamine tolerance and endocrine organs of the rat. Acta Endocrinol. (Copenh.) 34, 619–626 (1960)
Samorajski, T., Ordy, J.M., Rolsten, C.: Prenatal chlorpromazine effects on liver enzymes, glycogen and ultrastructure in mice offspring. Am. J. Pathol. 47, 803–831 (1965)
Sams, W.M., Jr., Epstein, J.H.: The experimental production of drug phototoxicity in guinea pigs. J. Invest. Derm. 48, 89–94 (1967)
Saunders, D.R., Miva, T.S., Mennear, J.H.: Chlorpromazine-ultraviolet interaction on mouse ear. Pharmacologist 13, 241 (1971)
Scanlan, F J.: The use of thioridazine (Melleril) during the first trimester. Med. J. Aust. 1, 1271–1272 (1972)
Schanda, H.: Kardiovaskuläre Nebenwirkungen trizyklischer Psychopharmaka unter besonderer Berücksichtigung des EKG. Fortschr. Neurol. Psychiatr. 45, 491–500 (1977)
Schardein, J.L.: Drugs as teratogens. Cleveland, Ohio: CRC Press 1976
Scheckel, C.L.: Pharmacology and chemistry of the thioxanthenes with special reference of chlorprothixene. Mod. Probl. Pharmacopsychiatry 2, 1–14 (1969)
Schiele, B.C.: Symposium on side-effects and drugs toxicity, including behavioral toxicity. Psychopharmacol. Bull. 4, 56–61 (1967)
Scholz, O., Kretzschmar, E.: Tierexperimentelle Untersuchungen über die Megaphen-Wirkung auf die Leber. Langenbecks Arch. Chir. 283, 515–527 (1956)
Scholz, O., Kretzschmar, E.: Der cholestatische Effect des Megaphen und seine Beeinflussung durch Choleretika. Klin. Wochenschr. 36, 38–41 (1958)
Seay, P.H., Field, W.E.: Toxicological studies on haloperidol. Int. J. Neuropsychiatry [Suppl. 1] 3, 19–22 (1967)
Seifter, J., Glassman, J.M., Rauzzino, F.: Pharmacological properties of promazine. J. Pharmacol. Exp. Ther. 119, 183 (1957)
Shader, R.I., DiMascio, A.: Psychotropic drug side effects. Baltimore: Williams & Wilkins 1970
Shader, R.I., Harmatz, J.S.: Gastrointestinal effects. In: Psychotropic drug side effects. Shader, R.J., DiMascio, A. (eds.), pp. 198–205. Baltimore, Williams & Wilkins 1970
Shapiro, S., Heinonen, O.P., Siskind, V., Kaufmann, O.W., Monson, R.R., Slone, D.: Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Bendectin) in relation to congenital malformations, perinatal mortality rate, birth weight and intelligence quotient score. Am. J. Obstet. Gynecol. 128, 480–488 (1977)
Shaw, M.W.: Human chromosome damage by chemical agents. Annu. Rev. Med. 21, 409–432 (1970)
Silvestrini, B., Quadri, E.: Investigations on the specificity of the so-called analgesic activity of non-narcotic drugs. Eur. J. Pharmacol. 12, 231–235 (1970)
Similä, S., Raijola, E., Raijola, A.: Effect of reserpine and meprobamate on the functional status of rat seminal vesicles. Ann. Med. Exp. Biol. Fenn. 40, 313–317 (1962)
Simmons, J.E., Lusk, M.: Response of neonatal female rats to reserpine and testosterone. Acta Endocrinol. (Copenh.) 61, 302–306 (1969)
Singh, S., Padmanabhan, R.: Prenatal stunting of CF rats caused by maternal administration of chlorpromazine hydrochloride. Teratology 16, 122–123 (1977)
Sjöstrand, S.E., Cassano, G.B., Hansson, E.: The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography. Arch. Int. Pharmacodyn. Ther. 156, 34–41 (1965)
Smejkal, V.: Action of reserpine on the digestive tract of experimental animals. Byul. Eksp. Biol. Med. 63, 157–158(1968)
Smithells, R.W.: Phenothiazines and teratogenicity. Practitioner 205, 836 (1970)
Smoliyanikova, N.M., Strekalova, S.N., Boiko, S.S.: Regularities governing penetration of chlorpromazine via the placental barrier. Farmakol. Toksikol. 39, 560–562 (1976)
Sobel, D.E.: Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch. Gen. Psychiatry 2, 606–611 (1960)
Soulairac, A., Soulairac, M.-L.: Action de la reserpine sur le comportement sexuel du rat male. C.R. Soc. Biol. (Paris) 155, 1010–1013 (1961)
Soulairac, A., Soulairac, M.-L.: Effect de l’administration chronique de réserpine sur la fonction génitale du rate male. Ann. Endocrinol. (Paris) 23, 281–292 (1962)
Spieth, K.D., Lorenz, D.: Untersuchungen mit Fluphenazin und Flupenthixol über die Beeinflussung der Fertilität und über die fetale Toxizität an der Ratte. Arch. Pharmakol. Exp. Pathol. 257, 338–339 (1967)
Stamp, J.T.: Perinatal loss in lambs with particular reference to diagnosis. Vet. Rec. 81, 530–534 (1967)
Stoffer, S.S.: A gynecologic study of drug addicts. Am. J. Obstet. Gynecol. 101, 779–783 (1968)
Szabo, K.T., Brent, R.L.: Species differences in experimental teratogenesis by tranquilizing agents. Lancet 1974 I, 565
Szabo, K.T., Brent, R.L.: Reduction of drug-induced cleft palate in mice. Lancet 1975 I, 1296–1297
Szabo, K.T., Difebbo, M.E., Kang, Y.J., Brent, R.L.: Teratological evaluation of tranquilizing agents in various species of laboratory animals. Preliminary report. Teratology 10, 325 (1974)
Szabo, K.T., Difebbo, M.E., Kang, Y.J., Palmer, A.K., Brent, R.L.: Comparative embryotoxio ity and teratogenicity of various tranquilizing agents in mice, rats, rabbits and rhesus monkeys. Toxicol. Appl. Pharmacol. 33, 124 (1975)
Talwalker, P.K., Meites, J., Nicoll, C.S., Hopkins, T.F.: Effects of chlorpromazine on mammary glands of rats. Am. J. Physiol. 199, 1073–1076 (1960)
Teske, H.-J., Weicker, H.: Die Phenothiazin-Haemolyse im Tierexperiment. Ärztl. Forsch. 10, 236–247 (1956)
Tessitore, V.: Effetti della tioridazina sul sistema neurosecernente ipotalamo-neuroipofisario. Boll. Soc. Ital. Biol. Sper. 43, 379–381 (1967)
Thomas, J.O., McNaught, J.B., DeEds, F.: Studies on phenothiazine, VI. General toxicity and blood changes. J. Ind. Hyg. Toxicol. 20, 419–421 (1938)
Tonge, S.R.: Permanent alterations in catecholamine concentrations in discrete areas of brain in the offspring of rats treated with methylamphetamine and chlorpromazine. Br. J. Pharmacol. 47, 425–427 (1973 a)
Tonge, S.R.: Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain. Proc. Br. Pharmacol. Soc. 48, 364–365 (1973 b)
Torjescu, V.: Etude enzymo-toxicologique de la chlorpromazine. Ann. Pharm. Fr. 26, 311–322 (1968)
Towell, M.E., Hyman, A.I., James, L.St., Steinsland, O.S., Gerst, E.C., Adamsons, K.: Reserpin administration during pregnancy. Am. J. Obstet. Gynecol. 92, 711–716 (1965)
Tripod, J., Bein, H.J., Meier, R.: Characterization of central effects of Serpasil (reserpine, a new alkaloid of rauwolfia serpentina B.) and of their antagonistic reactions. Arch. Int. Pharmacodyn. Ther. 96, 406–425 (1954)
Tuchmann-Duplessis, H.: Influence de la réserpine sur les glandes endocrines. Presse Méd. 64, 2189–2192 (1956)
Tuchmann-Duplessis, H., Mercier-Parot, L.: Répercussions de la réserpine sur la gestation chez la ratte. C.R. Acad. Sci. [D] (Paris) 243, 410–413 (1956)
Tuchmann-Duplessis, H., Mercier-Parot, L.: Influence de traitements de réserpine sur la fertilité des parents et de leurs descendants. C.R. Soc. Biol. (Paris) 156, 587–590 (1962)
Tuchmann-Duplessis, H., Mercier-Parot, L.: Action d’un neuroleptique, le R 1625 (haloperi-dol) sur l’activité génitale de la ratte. CR. Soc. Biol. (Paris) 263, 1493–1495 (1966)
Tuchmann-Duplessis, H., Mercier-Parot, L.: Nidation retardée sous l’influence d’un neuroleptique, le R 1625 (haloperidol). C R. Soc. Biol. (Paris) 264, 114–117 (1967)
Tuchmann-Duplessis, H., Mercier-Parot, L.: Retentissements endocrines de certains médicaments neurotropes. Proc. Eur. Soc. Study Drug Toxi. 9, 119–133 (1968)
Ullberg, S., Lindquist, N.G., Sjostrand, S.E.: Accumulation of chorio-retinotoxic drugs in the foetal eye. Nature 227, 1257–1258 (1970)
Usdin, E.: Absorption, distribution and metabolic fate of psychotropic drugs. Psychopharmacol. Bull. 6, 4–25 (1970)
van den Berghe, H.: Clastogenic effects of haloperidol in vivo and of haloperidol, droperidol and pipamperone in vitro. Arzneim. Forsch. 24, 2055–2058 (1974)
van Waes, A., van de Velde, E.: Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J. Clin. Pharmacol. 9, 224–227 (1969)
Vapaatalo, H.I., Karppanen, H.: Influence of ethanol on the toxicity of some psychotropic drugs. Scand. J. Clin. Lab. Invest. [Suppl. 108] 23, 77 (1969)
Vapaatalo, H.I., Idänpään-Heikkila, J.E., Neuvonen, P.J.: Effects of prolonged chlorpromazine treatment on the rat intestine. Acta Pharmacol. Toxicol. (Copenh.) 27, 262–268 (1969)
Verne, J. Tuchmann-Duplessis, H., Hébert, S.: Etude comparative de l’influence exercée par la réserpine et par l’hypophysectomie sur le testicule et la vésicule séminale du rat. Ann. Endocrinol. (Paris) 18, 952–958 (1957)
Vince, DJ.: Congenital malformations following phenothiazine administration during pregnancy. Can. Med. Assoc. J. 100, 223 (1969)
Wagner, M.: Die Wirkung einiger gebräuchlicher Piperidinderivate auf menschliche Chromosomen in vitro. Arzneim. Forsch. 21, 1017–1024 (1971)
Walker, B.E., Patterson, A.: Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology 10, 159–164 (1974)
Walker, C.A., Friedman, A.H.: Twenty-four hour toxicity rhythms of sympathomimetic amines in mice. Pharmacologist 12, 198 (1970)
Walson, P.D., Lightner, E.S., Harris, T.H., Sell, E.J.: The first reported case in a neonate of gynecomastia and lactation following the use of chlorpromazine (thorazine). Clin. Res. 23, 143 (1975)
Wang, G.M., Wong, K.K., Dreyfuss, J., Schreiber, E.C.: Effect of tricyclic psychoactive agents on levels of K+ and reduced glutathione (GSH) in rabbit lenses in vitro and on hemolysis: The implication for cataractogenicity. Clin. Pharmacol. Ther. 13, 155 (1972)
Wattenberg, L.W., Leong, J.L.: Effects of phenothiazines on protective systems against poly-cyclic hydrocarbons. Cancer Res. 25, 365–370 (1965)
Watzman, N., Manian, A.A., Barry III, H., Buckley, J.P.: Comparative effects of chlorpromazine hydrochloride and quaternary chlorpromazine hydrochloride on the central nervous system of rats and mice. J. Pharm. Sci. 57, 2089–2093 (1968)
Weikel, J.H., Wheeler, A.G., Joiner, P.D.: Metabolic fate and toxicology of methdilazine 10-(I-methyl-3-pyrrolidylmethyl) phenothiazine. Toxicol. Appl. Pharmacol. 2, 68–82 (1960)
Weiss, B., Santelli, S., Lusink, G.: Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology 53, 289–293 (1977)
Weissmann, A.: Psychopharmacological effects of thiothixene and related compounds. Psychopharmacologia 12, 142–157 (1968)
Werboff, J.: Tranquilizers in pregnancy and behavioral effects on the offspring. Nature 209, 110 (1966)
Werboff, J., Dembicki, E.L.: Toxic effects of tranquilizers administered to gravid rats. J. Neuropsychiatry 4, 87–91 (1962)
West, G.B.: Some factors influencing histamine metabolism in rat pregnancy. Int. Arch. Allergy Appl. Immunol. 16, 39–48 (1960)
West, G.B.: Teratogenic activity of drugs. J. Pharm. Pharmacol. 16, 63–64 (1964)
Windle, W.F., Cammermeyer, J., Smart, J.O., Joralemon, J., Dorrill, E., McQuillan, M.P., Feringa, E.R., Pimentai, L.T.: Tremor, rigidity, akinesia and associated phenomena in reserpinised african green monkeys (motion picture). Am. J. Physiol. 183, 674 (1955)
Winter, D.: Toxizitätsveränderung neurotroper Pharmaka bei Versuchstieren mit experimentell hervorgerufener Hyperthyreoidie. Med. Pharmacol. Exp. 14, 391–394 (1966)
Wolf, H.G.: Pränatale und neonatale Schädigungen durch Arzneimittel. Wien. Klin. Wochenschr. 80, 498–502 (1968)
Zeilmaker, G.H.: Normal and delayed pseudopregnancy in the rat. Acta Endocrinol. (Copenh.) 49, 558–566 (1965)
Zimmermann, H.J.: Toxic hepatopathy Am. J. Gastroenterol. 49, 39–56 (1968)
Zipf, H.F., Alstaedter, A.: Die hypnotische Wirkung von Luminal und Evipan in Kombination mit Megaphen und anderen Phenothiazin-Derivaten. Arzneim. Forsch. 4, 14–19 (1954)
Ziv, G., Shani, J., Givant, Y., Buchman, O., Sulman, F.G.: Distribution of triated haloperidol in lactating and pregnant cows and ewes. Arch. Int. Pharmacodyn. Ther. 212, 154–163 (1974)
Zoryan, V.G.: Effect of reserpine on the hypothalamo-hypophysial-adrenocortical system. A review. Farmakol. Toksikol. 29, 370–377 (1966)
Zucker, L, Feder, H.H.: The effect of neonatal reserpine treatment on female sex behavior of rats. J. Endocrinol. 35, 423–424 (1966)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leuschner, F., Neumann, W., Hempel, R. (1980). Toxicology of Antipsychotic Agents. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67538-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-67538-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67540-9
Online ISBN: 978-3-642-67538-6
eBook Packages: Springer Book Archive